3DConsultants directors will attend the Tau Consortium Investigators' Meeting (TCIM 2023) in Boston. The meeting will focus on accelerating the development of new treatments for Alzheimer’s disease, frontotemporal dementias, and other neurodegenerative diseases involving the dysfunctional tau protein.
Comments